LyGenesis Inc. — Form D/A
LyGenesis Inc. of PITTSBURGH, PA, a company, filed a Form D amendment with the SEC on 2024-10-11. The offering totals $20.0M, of which $17.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-10-11
- Form: D/A
- Accession: 0000898432-24-000826
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $17.8M
- Remaining: $2.2M
- Investors: 17
- Date of first sale: 2023-10-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-494568
Issuer
- Name: LyGenesis Inc.
- CIK: 0001739872
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1710 Murray Ave, PITTSBURGH, PA, 15217
- Phone: 412-449-9983
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Justin Briggs | Director | Sunnyvale, CA |
| Steve Felstead | Director | Earlston, X0 |
| Michael Hufford | Director | Pittsburgh, PA |
| Eric Lagasse | Director | Pittsburgh, PA |
| James Mellon | Director | New York, NY |
| Michael Hufford | Executive Officer | Pittsburgh, PA |
| Eric Lagasse | Executive Officer | Pittsburgh, PA |
| Michael Hufford | Promoter | Pittsburgh, PA |
| Gregory Bailey | Director | Road Town, Tortola, D8 |
| Paulo Fontes | Executive Officer | Pittsburgh, PA |
| Paulo Fontes | Promoter | Pittsburgh, PA |
| Eric Legasse | Executive Officer | Pittsburgh, PA |
| Eric Legasse | Promoter | Pittsburgh, PA |
Other filings by this issuer (4)
More